5,610 UnitedHealth Group Incorporated $UNH Shares Sold by Lockheed Martin Investment Management Co.

Posted by Geri Gentry on Nov 10th, 2026

Lockheed Martin Investment Management Co. lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 38.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,160 shares of the healthcare conglomerate’s stock after selling 5,610 shares during the quarter. Lockheed Martin Investment Management Co.’s holdings in UnitedHealth Group were worth $3,362,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Corient Private Wealth LP bought a new position in UnitedHealth Group in the 2nd quarter valued at approximately $245,516,000. Legal & General Group Plc bought a new stake in shares of UnitedHealth Group during the second quarter worth $2,444,928,000. Jupiter Topco LLC acquired a new position in shares of UnitedHealth Group during the second quarter worth $2,019,844,000. BlackRock Inc. lifted its stake in shares of UnitedHealth Group by 4.6% in the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after acquiring an additional 3,395,530 shares during the last quarter. Finally, Canada Pension Plan Investment Board bought a new position in shares of UnitedHealth Group in the 2nd quarter valued at $971,757,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.19% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research reports. Robert W. Baird reduced their price objective on UnitedHealth Group from $453.00 to $427.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 14th. UBS Group reiterated an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday, October 13th. Bank of America restated a “buy” rating and set a $450.00 price target on shares of UnitedHealth Group in a report on Monday, July 20th. Erste Group Bank downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, August 27th. Finally, Royal Bank Of Canada boosted their target price on shares of UnitedHealth Group from $478.00 to $498.00 and gave the stock an “outperform” rating in a report on Tuesday, October 20th. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $463.93.

Read Our Latest Report on UnitedHealth Group

UnitedHealth Group Stock Performance

NYSE:UNH opened at $396.97 on Tuesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74. UnitedHealth Group Incorporated has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The company has a 50 day simple moving average of $390.68 and a two-hundred day simple moving average of $364.28. The company has a market capitalization of $355.70 billion, a PE ratio of 22.67, a P/E/G ratio of 1.48 and a beta of 0.51.

UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm had revenue of $112.72 billion for the quarter, compared to the consensus estimate of $111.31 billion. During the same quarter in the previous year, the company earned $2.59 EPS. The company’s revenue for the quarter was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be issued a $2.32 dividend. The ex-dividend date is Monday, December 7th. This represents a $9.28 annualized dividend and a yield of 2.3%. UnitedHealth Group’s payout ratio is presently 53.00%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid.

Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Founded in 1977 as United HealthCare Corporation, the company is headquartered in Minnetonka, Minnesota.